Skip to main content

Advertisement

Table 2 Objective responses and survival of the study population

From: The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer

Variable No. of Patients [cases (%)] Median PFS Median OS
(95% CI, months) (95% CI, months)
Best response
 Complete response 0
 Partial response 21 (32.3) 7.80 (4.86–10.74) 18.17 (12.89–23.45)
 Stable disease 27 (41.5) 7.00 (4.43–9.57) 13.00 (9.68–16.32)
 Progressive disease 16 (24.6) 1.93 (1.59–2.28) 4.30 (3.58–5.02)
 Could not be evaluated 1 (1.5)
Objective response ratea 21 (32.3)
Disease control rateb 48 (73.8)
  1. OS overall survival, PFS progression free survival, CI confidence interval
  2. aThe rate of objective response was defined as the percentage of patients who had a complete response or a partial response
  3. bThe rate of disease control was defined as the percentage of patients who had a complete response, partial response, or stable disease